Safety Alerts & Recalls
Search all Safety Alerts & Recalls
Latest Alerts
Recall on Single Lot of Barr Laboratories Brand Dextroamphetamine/Amphetamine 20mg Tablets
Barr Laboratories, Inc. has recalled a single lot of Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate (mixed amphetamine salts) 20mg tablets. The lot number involved in the recall is lot number 311756. The affected lot was available to patients after June 11, 2009.
These tablets may be oversized and contain more drug than appropriate. This could result in patients receiving more than the expected dosage of this drug.
Dextroamphetamine/Amphetamine is used in the treatment of narcolepsy and attention deficit disorder and is also known by the brand names Adderall and Adderall XR. However, Barr Laboratories lot number 311756 is the only lot involved and no other lot numbers, strengths, or brands of Dextroamphetamine/Amphetamine are affected by this recall.
For more information, please visit:
http://www.fda.gov/Safety/Recalls/ucm177321.htm
Learn More
Cases of Anemia Reported in Patients Treated with CellCept
Roche notified healthcare professionals that cases of Pure Red Cell Aplasia (PRCA) have been reported in patients treated with CellCept (mycophenolate mofetil) in combination with other immunosuppressive agents. Pure Red Cell Aplasia is a type of anemia where the bone marrow slows or stops production of red blood cells. The WARNINGS and ADVERSE REACTIONS sections of the CellCept Prescribing Information have been revised to reflect this new safety information.
For more information, please visit:
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm177397.htm
Learn More